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 2011 2012 2013 2014 
Radiation Oncologist 59% 18% 6% 4% 
Medical Physicists 4.5% 7% 2% 2% 
Dosimetrists - 5% - 7% 
Radiation Therapists 32% 70% 91% 87% 
Nurses 4.5% - - - 
Medical Secretary - - - 1% 
Nº of Events 22 44 120 112 
 
Dose errors were detected in 29 patients. In 9 patients 
afected more than 1 session (5 patients in 2011, 3 patients in 
2012, 1 patient in 2013 and no patients in 2014).  
The number of corrective actions has increased because of 
the increasing number of registered events: 2 in 2011, 4 in 
2012, 7 in 2013 and 9 in 2014. 
 
Conclusion: Event reporting and learning systems in 
radiotherapy can provide valuable data for patient safety 
treatment. An open acces event reporting improved 
identification of areas which needed process and safety 
improvements. The major indication of the effectiveness is 
the reduction in dose errors. 
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Purpose or Objective: Reference dosimetry audit 
measurements in UK radiotherapy centres have been carried 
out over the last 20 years. This work examines the variation 
in local dosimetry calibration in a network of radiotherapy 
centres, draws conclusions on the implementation of an 
absorbed dose based protocol for MV photon beams and 
includes the measured effect of a change in the nationally 
recommended electron code of practice (CoP) from an air 
kerma based to an absorbed dose based protocol. 
 
Material and Methods: Data from reference dosimetry audits 
conducted in radiotherapy centres by the National 
Measurement Institute (NMI) for photon, electron and kV x-
rays have been collated, recording the NMI:Centre ratio for 
reference output measurements, beam quality, and field 
chamber comparison. A total of 81 MV photon, 98 electron 
and 30 kV photon beams were measured during 68 visits 
between June 1994 and February 2015. The change in the 
national standard deviation has been assessed over time, and 
differences due to the change between the two electron CoPs 
during this period has been quantified. The improvement in 
consistency for MV beams since the adoption of a CoP 
traceable to a primary standard of absorbed dose is assessed. 
 
Results: The mean NMI:Centre difference for radiation 
output calibration was less than 0.25% for all modalities. A 
total of 7 measurements were reported to be outside the +/-
2% tolerance.There was a statistically significant difference 
(p=0.008) in the mean result for the respective air kerma 
based electron CoP, +0.75% (n=14) with the absorbed dose 
based protocol giving +0.20% (n=84). 
The variation in MV results has decreased steadily over time 
(see Figure 1). The standard deviation has halved when 
comparing the first and last 20 results, being 0.85% (2000) 
and 0.35% (2015). This trend has also been noted within 
regional audit groups. A linear correlation was observed 
between the ‘NMI:Centre output ratio’ and the ‘NMI:Centre 
field chamber comparison ratio’. 
There has been no significant difference observed between 
regional audit and national audit for the measured 
NMI:Centre ratios, but some regions have had many more NMI 
audits than others, some having no beams audited for a 
particular modality, and others having more than 20. 
 
Conclusion: Data has been collated from 20 years of NMI 
reference dosimetry audits, and key trends and changes have 
been noted. The introduction of the 2003 absorbed dose-
based electron CoP has decreased the difference between 
NMI and centre measured outputs. The use of a single 
absorbed dose based MV CoP, introduced just prior to the 
start of these audits, has contributed to the improved 
consistency demonstrated in these results. This not only 
shows the impact of a rigorous traceability chain developed 
by close collaboration between NMI and end users but also 
demonstrates that the NMI audit programme is likely to be a 
contributing factor to this improvement in consistency in 
dosimetry nationally. 
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Purpose or Objective: In the DBCG HYPO trial a number of 
radiation therapy (RT) parameters were prospectively 
determined for each individual treatment plan. These 
parameters were reported to a database and analyzed to 
determine the plan quality in the trial. 
 
Material and Methods: Patients (pts) for breast-only RT after 
surgery for early node-negative breast cancer from 8 RT 
centre in 3 countries were included in the trial between May 
2009 and March 2014. They were randomized to either 40 
Gy/15 fx or 50 Gy/25 fx. A number of plan-quality 
parameters such as doses to CTV-breast and organs at risk 
were determined for each plan. The use of respiratory gating 
during treatment was reported. Definitions on compliance to 
protocol guidelines, as well as minor and major deviations 
(Table 1) were agreed upon before trial start. After closing 
the trial, the QA parameters were analyzed and scored. 
 
